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A cohort of 63090 Norwegian women born 1886–1928 was followed more than 38 years, and relations between reproductive
factors and risk of pancreatic cancer were explored; 449 cases were recorded at ages 50–89 years. Age at menopause showed a
moderately positive association with risk (rate ratio (RR)¼1.08 per 2 years delay in menopause; 95% confidence interval
(CI)¼1.00–1.17). Neither parity nor duration of breastfeeding showed significant associations with risk after adjusting only for
demographic factors. With mutual adjustment, however, parity became positively associated (RR¼1.13 per delivery; 95% CI¼1.05–
1.22) while duration of breastfeeding was inversely associated (RR¼0.87 per 12 months; 95% CI¼0.78–0.97). These associations
lessened in magnitude with increasing age, and were essentially absent above age 80 years. Risk was raised among women reporting
at least one abortion, but no trend was seen with number of abortions. Together with previous studies, the findings raise questions
about the role of chance, but do not exclude hormonal factors related to breastfeeding and pregnancy from affecting pancreatic
cancer risk.
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Among Norwegian women, only cancers of lung, breast, colon and
ovary cause more deaths than pancreatic cancer (Cancer Registry
of Norway, 2006). Female sex hormones may be involved in the
aetiology of pancreatic cancer (Robles-Diaz and Duarte-Rojo,
2001), with experimental studies indicating that carcinogenesis
may be promoted as well as inhibited by steroid hormones.
Findings regarding expression of oestrogen receptors have been
inconsistent (Satake et al, 2006), although both oestrogen and
progesterone receptors have been found in normal and neoplastic
pancreatic tissue (Robles-Diaz and Duarte-Rojo, 2001).
Lower incidence rates of pancreatic cancer in women than men,
particularly at premenopausal ages, have suggested that sex
hormones may be protective in women (Bourhis et al, 1987).
However, although Norwegian women traditionally had much
lower incidence than men, this difference has narrowed consider-
ably in the last 20 years (Cancer Registry of Norway, 2006), while
the remaining contrast may reflect risk factors such as smoking.
Some studies have indicated overall positive (Miller et al, 1980;
Ji et al, 1996) or inverse relations with parity (Kreiger et al, 2001;
Skinner et al, 2003). Others showed a higher (Karlson et al, 1998;
Navarro Silvera et al, 2005) or lower (Hanley et al, 2001; Teras
et al, 2005) risk among women with many children only or even no
association with parity (Duell and Holly, 2005; Prizment et al,
2007). Breastfeeding was covered in only two studies (Skinner et al,
2003; Lo et al, 2007) while menstrual factors have shown
inconclusive findings (Prizment et al, 2007).
We investigated reproductive factors in relation to pancreatic
cancer during a 38-year follow-up of a cohort of Norwegian women
born over the period 1886–1928. Results after shorter periods of
follow-up were reported previously for parity (Kva ˚le et al, 1994)
and duration of breastfeeding (Kva ˚le and Heuch, 1988).
MATERIALS AND METHODS
The cohort consisted of women who participated in a breast
cancer-screening programme in 1956–1959 in the Norwegian
counties of Nord-Trøndelag, Aust-Agder and Vestfold. A detailed
questionnaire, completed in personal interviews, covered repro-
ductive factors (Kva ˚le, 1989). No distinction was made between
spontaneous and induced abortions, but in the birth cohorts
considered most abortions would have been spontaneous. Where
relevant, information on age at menopause was also recorded,
defined as age at last menstruation. Among the 85063 women
resident in the three counties aged 32–74 years by 1 January 1961,
a total of 63090 women attended and were interviewed.
Using personal identification numbers, data on reproductive
factors were, with approval from the Norwegian Data Inspectorate,
linked to follow-up information on deaths and emigration from
Statistics Norway and to cancer diagnoses from the Cancer
Registry of Norway.
Follow-up extended from 1 January 1961 until 31 December
1998 and terminated at diagnosis of pancreatic cancer, at age 90
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yyears, death or emigration. Only five cases of pancreatic cancer
occurred under age 50 years, and in the present study the follow-
up started at age 50 years. Of the 62613 women followed, 33769
died and 148 emigrated or were removed from the population
registry. They contributed a total of 1505163 person-years, with a
mean follow-up time of 24 years. A total of 449 cases of pancreatic
cancer (ICD 7, code 157) were recorded, among them 231 were
histologically verified. Among the remaining cases, the diagnosis
was based on surgical reports in 99 cases, X-ray examinations in 60
cases, clinical examinations in 31 cases, autopsy in 4 cases and
death certificates in 24 cases.
Incidence rates were assessed by log-linear Poisson regression
analysis (Preston et al, 1996), taking into account the person-years
for the various risk factor levels. Age was regarded as a time-
dependent variable. Estimated linear relations were based on the
original values recorded, in years for age and months for duration
of breastfeeding, and not the grouped values used to study
categorical effects.
Age at menopause was studied in the 22145 women known to be
postmenopausal at the time of interview, among whom 192 cases
of pancreas cancer occurred. Because of missing values, the
numbers in analyses of other risk factors varied slightly.
Measurements of height and weight were carried out separately
in 1963–1975 in a subcohort. In analyses adjusted for body mass
index (BMI), defined as weight/(height)
2, follow-up started 2 years
after the measurements to reduce a possible effect of disease on
weight; these included 49055 women, with 329 cases.
Information on individuals’ smoking habits, a potential
confounder, was not available. Absolute age-specific incidence
rates of lung cancer (ICD 7, codes 162 and 163), during follow-up,
were used to assess the extent of smoking. To compare birth
cohorts, only the age intervals 60–64, 65–69, 70–74 and 75–79
years were considered, with a total of 393 cancer cases.
RESULTS
Pancreatic cancer showed only minor variation in incidence over
birth cohorts after accurate adjustment for age (Table 1) but
differed moderately between the three counties. Risk was rather
similar in broad occupational categories of the women or of their
husbands, regarded as indicators of socioeconomic status (results
not shown).
No association was found between age at menarche and risk
(Table 2). Age at menopause showed a moderately positive
association, particularly for women experiencing menopause
above age 50 years (Table 2). Excluding women who reported
oophorectomy, hysterectomy or other operations on the ovaries or
uterus showed similar risk estimates among the remaining 19728
women with natural menopause (results not shown). The number
of fertile years, defined as the period between menarche and
menopause, did not show any additional association with risk
above that seen with age at menopause (rate ratio (RR)¼1.07 per 2
years in a linear analysis including 187 cases; 95% confidence
interval (CI)¼0.99–1.14).





cases RR (with 95% CI)
Age (years)
a
50–59 4.09 36 0.42 (0.28–0.61)
60–69 5.14 112 1.00
b
70–79 4.24 192 2.03 (1.60–2.58)
80–89 1.59 109 2.97 (2.25–3.93)
Birth cohort
c
1886–1900 2.19 104 1.00
b
1901–1910 4.25 150 1.01 (0.79–1.30)
1911–1920 5.47 138 0.93 (0.72–1.22)







Aust-Agder 3.27 88 0.81 (0.63–1.06)
Vestfold 6.65 197 0.93 (0.76–1.15)
CI¼confidence interval; RR¼rate ratio.
aRRs adjusted for birth cohort.
bReference
category.
cRRs adjusted for age (in 2-year categories).
dRRs adjusted for age (in 5-year
categories) and birth cohort.


























2 96 0.90 (0.66–1.23) 0.97 (0.69–1.35)
3 93 1.25 (0.91–1.71) 1.47 (1.03–2.09)
4 48 1.16 (0.80–1.69) 1.49 (0.98–2.26)
X5 44 1.11 (0.75–1.64) 1.63 (1.01–2.64)
Per
delivery
1.03 (0.98–1.09) 0.21 1.13 (1.05–1.22) 0.002





1–6 62 0.61 (0.41–0.91) 0.62 (0.42–0.93)
7–12 73 0.66 (0.45–0.97) 0.66 (0.44–0.97)
13–24 92 0.68 (0.47–0.98) 0.63 (0.42–0.93)
25–36 50 0.65 (0.43–0.99) 0.50 (0.31–0.78)
436 31 0.56 (0.34–0.90) 0.40 (0.23–0.70)
Per 12
months
0.95 (0.87–1.03) 0.23 0.87 (0.78–0.97) 0.01
CI¼confidence interval; RR¼rate ratio.
aAmong all women with known parity and
duration of breastfeeding.
bReference category.
cAmong parous women with known
duration of breastfeeding.







Age at menarche (years)
a
p12 42 1.06 (0.75–1.50)
13 82 1.15 (0.87–1.52)
14 131 1.00
b
15 102 1.08 (0.83–1.40)
X16 73 1.02 (0.77–1.36)
Per year 0.99 (0.93–1.06) 0.86




48–49 33 1.05 (0.68–1.63)
50–51 58 1.47 (1.02–2.14)
X52 44 1.37 (0.92–2.06)
Per 2 years 1.08 (1.00–1.17) 0.03
CI¼confidence interval; RR¼rate ratio.
aRRs adjusted for age (in 5-year categories),
birth cohort and county.
bReference category.
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yNo statistically significant relations were found with parity or
total duration of breastfeeding, adjusting for demographic
variables only (Table 3). With adjustment for breastfeeding,
however, a significant positive relation emerged with parity,
nulliparous having the lowest risk (RR¼0.61, 95% CI¼0.42–0.90)
compared to all parous women. Women with three or more
deliveries had an elevated risk (Table 3). Similarly, a significant
inverse relation was found with duration of breastfeeding after
adjusting for parity. Parous women who had not breastfed had a
higher risk than any category who did, and also within each
category of parity. Rate ratios for those who breastfed compared to
those who did not were 0.60, 0.56, 0.85, 0.54 and 0.39, for women of
parity 1, 2, 3, 4 and X5, respectively. Risk declined further for
quite long breastfeeding periods (Table 3). Excluding women with
no breastfeeding still indicated an inverse although slightly weaker
linear relation with the total breastfeeding period (RR¼0.90 per 12
months of breastfeeding; 95% CI¼0.80–1.01); no linear interac-
tion could be demonstrated between parity and duration
(P¼0.55). Age at menopause was only weakly associated with
parity and breastfeeding in this cohort (Kva ˚le, 1989) and further
adjustment for age at menopause had little effect.
Analyses of age at delivery in uniparous women and for ages at
first or last delivery in multiparous women showed no association
with risk (Table 4). Women reporting at least one abortion showed
a higher risk than those without abortions (Table 5), but no trend
was seen with the number of abortions.
Linear analyses were performed for parity, duration of
breastfeeding and age at menopause within broad categories
defined by attained age and birth cohort. No significant
interactions were found with age or birth cohort, but the effects
of all three risk factors essentially disappeared above about 80
years (Table 6). Risk estimates for duration of breastfeeding based
on linear analyses were remarkably stable over birth cohorts.
Analyses restricted to histologically verified cases produced
similar linear estimates with parity (RR¼1.12 per delivery; 95%
CI¼1.01–1.24) and duration of breastfeeding (RR¼0.88 per 12
months; 95% CI¼0.75–1.02). For age at menopause, a slightly
stronger estimate was found (RR¼1.11 per 2 years; 95%
CI¼0.99–1.24). Body mass index showed no association with
risk, and adjusting for it did not influence relations with age at
menopause, parity or breastfeeding, and nor materially did
occupational category.
Absolute incidences per 100000 person-years of lung cancer for
the birth cohort 1886–1900 were 6, 10, 16 and 28 for the age
intervals 60–64, 65–69, 70–74 and 75–79 years, respectively. For








Age at delivery (years), uniparous women
p24 13 0.92 (0.46–1.84)
25–29 22 1.00
b
30–34 13 0.67 (0.33–1.33)
X35 15 0.94 (0.47–1.87)
Per 5 years 0.96 (0.77–1.19) 0.71
Age at first delivery (years), multiparous women
c
p24 121 1.11 (0.82–1.49)
25–29 98 1.00
b
30–34 38 0.98 (0.66–1.46)
X35 14 1.26 (0.67–2.34)
Per 5 years 1.01 (0.84–1.21) 0.93
Age at last delivery (years), multiparous women
d
p29 53 0.86 (0.60–1.24)
30–34 94 1.00
b
35–39 82 0.89 (0.64–1.23)
X40 42 0.86 (0.56–1.33)
Per 5 years 1.05 (0.89–1.24) 0.54
CI¼confidence interval; RR¼rate ratio.
aAmong parous women with known age at
deliveries and duration of breastfeeding; rate ratios adjusted for age (in 5-year
categories), birth cohort, county and duration of breastfeeding.
bReference category.
cAdditional adjustment for parity and age at last delivery.
dAdditional adjustment for
parity and age at first delivery.









1 81 1.42 (1.10–1.82)
2 21 1.27 (0.81–1.98)
X3 6 0.89 (0.39–1.99)
Per abortion 1.10 (0.96–1.25) 0.18
c
Any abortion vs no abortion 1.34 (1.07–1.68) 0.01
CI¼confidence interval; RR¼rate ratio.
aRRs adjusted for age (in 5-year categories),




Table 6 Risks by parity, duration of breastfeeding and age at menopause in categories of age and birth cohort
Parity
a Duration of breastfeeding

















Age (years) 0.08 0.79 0.15
50–69 1.23 (1.09–1.40) 0.92 (0.75–1.11) 1.14 (0.96–1.34)
70–79 1.12 (1.00–1.25) 0.79 (0.67–0.93) 1.12 (1.00–1.26)
80–89 1.03 (0.86–1.23) 0.98 (0.78–1.22) 1.01 (0.90–1.14)
Birth cohort 0.36 0.63 0.83
1886–1900 1.09 (0.95–1.26) 0.87 (0.72–1.05) 1.07 (0.97–1.18)
1901–1910 1.03 (0.89–1.20) 0.89 (0.73–1.09) 1.12 (0.99–1.25)
1911–1928 1.26 (1.12–1.41) 0.85 (0.71–1.02) —
e
CI¼confidence interval; RR¼rate ratio.
aAmong all women with known parity and duration of breastfeeding; adjustment for age (in 5-year categories), birth cohort, county and
breastfeeding.
bAmong parous women with known duration of breastfeeding; adjustment for age, birth cohort, county and parity.
cAmong women with known age at
menopause; adjustment for age, birth cohort and county.
dBetween original values of risk factor and 5-year scores for age or 10-year scores for birth cohort.
eNo cases with
known age at menopause in this category.
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ythe birth cohort 1901–1910, the corresponding rates were 10, 15,
20 and 39; and for the birth cohort 1911–1928, 38, 65, 72 and 90.
DISCUSSION
In this cohort study, the risk of pancreatic cancer was influenced
by age at menopause and, after mutual adjustment, by parity and
duration of breastfeeding. The study design, with a complete and
lengthy follow-up, essentially eliminated selection bias. Data on
risk factors were collected before follow-up, and incomplete
information on reproductive variables, possibly affecting women
born after 1910, should mostly attenuate risks. Women with early
menopause were overrepresented, but after accurate adjustment
for age, this did not affect the risk estimates.
The lack of association with age at menarche is consistent with
certain previous studies (Ji et al, 1996; Kreiger et al, 2001; Skinner
et al, 2003; Navarro Silvera et al, 2005; Teras et al, 2005; Prizment
et al, 2007), although others found positive (Duell and Holly, 2005;
Lin et al, 2006) or inverse associations (Bueno de Mesquita et al,
1992; Kalapothaki et al, 1993; Fernandez et al, 1995; Hanley et al,
2001). A positive association with age at menopause was also
found in a population-based case–control study (Duell and Holly,
2005). An inverse relation in a cohort study (Prizment et al, 2007)
was heavily influenced by extreme values of age at natural
menopause, while no association was found by others (Bueno de
Mesquita et al, 1992; Ji et al, 1996; Kreiger et al, 2001; Skinner et al,
2003; Teras et al, 2005; Lin et al, 2006).
No significant relation with breastfeeding was found in a cohort
study of younger women with shorter overall breastfeeding times
(Skinner et al, 2003), while a case–control study, including
extended breastfeeding periods, showed an inverse relation (Lo
et al, 2007) consistent with our results.
A positive association with parity, seen only after adjustment for
breastfeeding, implied that multiparous women who never
breastfed carry an elevated risk. Multiparity and prolonged
breastfeeding may be associated with a lower risk than in
nulliparous women. Failure to take breastfeeding into account
may partly explain previous disparate results. Skinner et al (2003),
however, observed an inverse relation with parity even after
adjustment for breastfeeding. A positive association with parity
has been suggested as due to higher oestrogen levels, during
pregnancy (Ji et al, 1996), and if such effects fade over time, they
could produce an age interaction as seen in our study. As levels
drop substantially during breastfeeding (Baird et al, 1979), a
general risk-enhancing oestrogenic effect may also explain the
inverse association with breastfeeding, in addition to the positive
associations with abortions and age at menopause. Almost all
women in our cohort were born too early to have used oral
contraceptives or hormone replacement therapy, although these
apparently do not affect risk (Teras et al, 2005). Alternatively, the
breastfeeding effect may reflect the raised prolactin levels
maintained at these times (Freeman et al, 2000) since prolactin
causes a change in islet mass (Amaral et al, 2004). Although most
tumours occur in the exocrine pancreas, the islets seem to play a
role in carcinogenesis and may even harbour precursor cells
(Hennig et al, 2004). Prolonged breastfeeding has recently been
found to protect against subsequent type II diabetes (Stuebe et al,
2005) and diabetes may be a risk factor for pancreatic cancer
(Inoue et al, 2006), but these relations do not readily explain our
inverse association with breastfeeding.
It was not possible to adjust for cigarette smoking, a risk factor
for pancreatic cancer. Among Norwegian women born in 1890–
1894, the maximum proportion of smokers at any time was 10%,
but this increased to about 40% among those born in 1925–1929
(Rønneberg et al, 1994). Most women (79%) lived in rural
communities, with a considerably lower smoking prevalence
(Zeiner-Henriksen, 1976), particularly in the oldest cohorts,
containing the majority of cases. This was confirmed by lung
cancer incidence in this cohort, rates being similar for women
born before 1911 to non-smoking rates in Norway (Engeland et al,
1996) and for those born after 1910 were less than half the current
rates (Cancer Registry of Norway, 2006).
Smoking is associated with earlier menopause by 1–2 years
(Willett et al, 1983), so cannot explain our positive relation with
age at menopause. The association with parity was most
pronounced in the youngest birth cohorts, although risk estimates
by age showed more variation than by birth cohorts (Table 6). This
is unlikely to reflect confounding by smoking, which was first
adopted in Norway by higher socioeconomic women (Kreyberg,
1954) who have fewer children than the average, whereas our
breastfeeding effect was almost independent of birth cohort.
Potential confounding with obesity can be excluded, as BMI was
not associated with risk.
We found a higher risk among women reporting an abortion but
no trend in risk with the number. Possibly those with several
abortions reflected a tendency to miscarry early in pregnancy,
whereas factors associated with full-term pregnancy also applied
to the occasional later abortion. One early study (Lin and Kessler,
1981) showed an elevated risk in women after a spontaneous
abortion, but no associations were found in studies (Bueno de
Mesquita et al,1 9 9 2 ;F e r n a n d e zet al,1 9 9 5 ;J iet al, 1996; Rosenblatt
et al, 2006) that focused partly or wholly on induced abortions.
The lack of association with age at first birth is consistent with
several studies (Skinner et al, 2003; Duell and Holly, 2005; Navarro
Silvera et al, 2005; Teras et al, 2005; Lin et al, 2006; Prizment et al,
2007). However, two case–control studies (Fernandez et al, 1995;
Kreiger et al, 2001) found positive associations and a large
population-based study (Karlson et al, 1998) showed an inverse
association, especially below 50 years, outside our age range.
The variety of findings in epidemiological studies of pancreatic
cancer must raise the role of chance, although larger studies taking
into account hormonal levels in different age groups might still be
revealing.
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